San Diego-based biopharmaceutical company Medicinova announced this morning that it is moving to the NASDAQ Global Market, after approval by the Nasdaq Stock Market to list its securities there. The firm, which will trade under MNOV starting tomorrow, was previously traded on the Hercules Market of the Osaka Securities Exchange. Medicinova was the first American company to do an IPO in Japan, in early 2005.